CAMBRIDGE, Mass., Sept. 21 /PRNewswire-FirstCall/ -- Vertex
Pharmaceuticals Incorporated (Nasdaq: VRTX) will webcast its corporate
presentation at the 2005 UBS Global Life Sciences Conference. The
presentation will be delivered by Joshua Boger, Ph.D., Vertex's Chairman,
President and Chief Executive Officer, on Tuesday, September 27, 2005 at 12:00
p.m. EDT.
The presentation will be webcast live and may be accessed by visiting the
Vertex website at http://www.vrtx.com. A replay of the webcast will also be
available on the Company's website until October 11, 2005. To access the
webcast, go to Vertex's website and select 'UBS Global Life Sciences
Conference.' To ensure a timely connection to the webcast, it is recommended
that users register at least 15 minutes prior to the scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company
committed to the discovery and development of breakthrough small molecule
drugs for serious diseases. The Company's strategy is to commercialize its
products both independently and in collaboration with major pharmaceutical
companies. Vertex's product pipeline is principally focused on viral
diseases, inflammation, autoimmune diseases and cancer. Vertex co-promotes
the HIV protease inhibitor, Lexiva(R), with GlaxoSmithKline.
Lexiva(R) is a registered trademark of the GlaxoSmithKline group of
companies.
Vertex's press releases are available at http://www.vrtx.com.
Vertex Contact:
Lora Pike, Manager, Investor Relations, (617) 444-6755
SOURCE Vertex Pharmaceuticals Incorporated
 back to top
Related links:
http://www.vrtx.com
Company News On-Call:
http://www.prnewswire.com/comp/938395.html
CONTACT:
Lora Pike, Manager, Investor Relations of
Vertex, +1-617-444-6755
|
